What are the AACE treatment guidelines for dyslipidemia and prevention of CVD?

Updated: Jun 27, 2019
  • Author: Henry J Rohrs, III, MD; Chief Editor: Stuart Berger, MD  more...
  • Print

The 2017 AACE and American College of Endocrinology guidelines for management of dyslipidemia and prevention of CVD included the following recommendations for children and adolescents [3] :

  • In children at risk for FH (eg, family history of premature CVD or elevated cholesterol), screening should be at age 3 years, again between ages 9 and 11 years, and again at age 18 years.
  • Screen adolescents older than 16 years every 5 years or more frequently if they have atherosclerotic cardiovascular disease (ASCVD) risk factors, have overweight or obesity, have other  elements of the insulin resistance syndrome, or have a family history of premature ASCVD.
  • An LDL-C goal < 100 mg/dL is considered “acceptable” for children and adolescents, with 100 to 129 mg/dL considered “borderline” and 130 mg/dL or greater considered “high”.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!